• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡作为癌症治疗的一个潜在靶点。

Ferroptosis as a potential target for cancer therapy.

机构信息

Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Henan Key Laboratory of Tumor Molecular Therapy Medicine, Xinxiang, 453003, Henan Province, China.

Department of Biomedical Science, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam 13200, Kepala Batas, Pulau Pinang, Malaysia.

出版信息

Cell Death Dis. 2023 Jul 24;14(7):460. doi: 10.1038/s41419-023-05930-w.

DOI:10.1038/s41419-023-05930-w
PMID:37488128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10366218/
Abstract

Ferroptosis is a recently discovered essential type of cell death that is mainly characterized by iron overload and lipid peroxidation. Emerging evidence suggests that ferroptosis is a double-edged sword in human cancer. However, the precise underlying molecular mechanisms and their differential roles in tumorigenesis are unclear. Therefore, in this review, we summarize and briefly present the key pathways of ferroptosis, paying special attention to the regulation of ferroptosis as well as its dual role as an oncogenic and as a tumor suppressor event in various human cancers. Moreover, multiple pharmacological ferroptosis activators are summarized, and the prospect of targeting ferroptosis in cancer therapy is further elucidated.

摘要

铁死亡是一种新近发现的细胞死亡方式,主要特征为铁过载和脂质过氧化。有研究表明,铁死亡在人类癌症中是一把双刃剑。然而,其在肿瘤发生发展中的确切分子机制及其差异尚不清楚。因此,在这篇综述中,我们总结并简要介绍了铁死亡的关键途径,特别关注铁死亡的调控及其在各种人类癌症中作为致癌和抑癌事件的双重作用。此外,我们还总结了多种铁死亡激活剂,并进一步阐述了针对铁死亡在癌症治疗中的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/ae2d982248b8/41419_2023_5930_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/87686c78f5f0/41419_2023_5930_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/e81b233fbd40/41419_2023_5930_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/ae2d982248b8/41419_2023_5930_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/87686c78f5f0/41419_2023_5930_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/e81b233fbd40/41419_2023_5930_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f13a/10366218/ae2d982248b8/41419_2023_5930_Fig3_HTML.jpg

相似文献

1
Ferroptosis as a potential target for cancer therapy.铁死亡作为癌症治疗的一个潜在靶点。
Cell Death Dis. 2023 Jul 24;14(7):460. doi: 10.1038/s41419-023-05930-w.
2
Double-edge sword roles of iron in driving energy production versus instigating ferroptosis.铁在促进能量产生与引发铁死亡方面的双刃剑作用。
Cell Death Dis. 2022 Jan 10;13(1):40. doi: 10.1038/s41419-021-04490-1.
3
A double-edged sword with a therapeutic target: iron and ferroptosis in immune regulation.一把带有治疗靶点的双刃剑:免疫调节中的铁与铁死亡
Nutr Rev. 2023 Apr 11;81(5):587-596. doi: 10.1093/nutrit/nuac071.
4
Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers.靶向铁死亡用于癌症治疗:从其在癌症中的机制和作用探索新策略。
Transl Lung Cancer Res. 2020 Aug;9(4):1569-1584. doi: 10.21037/tlcr-20-341.
5
Pharmacological Targeting of Ferroptosis in Cancer Treatment.药物靶向治疗在癌症治疗中的应用。
Curr Cancer Drug Targets. 2022;22(2):108-125. doi: 10.2174/1568009621666211202091523.
6
Ferroptosis in inflammatory arthritis: A promising future.铁死亡在炎症性关节炎中的作用:充满希望的未来。
Front Immunol. 2022 Jul 26;13:955069. doi: 10.3389/fimmu.2022.955069. eCollection 2022.
7
PM2.5 induces ferroptosis in human endothelial cells through iron overload and redox imbalance.PM2.5 通过铁过载和氧化还原失衡诱导人内皮细胞发生铁死亡。
Environ Pollut. 2019 Nov;254(Pt A):112937. doi: 10.1016/j.envpol.2019.07.105. Epub 2019 Jul 30.
8
Iron, ferroptosis, and ischemic stroke.铁、铁死亡与缺血性中风。
J Neurochem. 2023 May;165(4):487-520. doi: 10.1111/jnc.15807. Epub 2023 Mar 27.
9
p53: A double-edged sword in tumor ferroptosis.p53:肿瘤铁死亡的双刃剑。
Pharmacol Res. 2022 Mar;177:106013. doi: 10.1016/j.phrs.2021.106013. Epub 2021 Nov 29.
10
Recent advances of ferroptosis in tumor: From biological function to clinical application.肿瘤中铁死亡的最新进展:从生物学功能到临床应用
Biomed Pharmacother. 2023 Oct;166:115419. doi: 10.1016/j.biopha.2023.115419. Epub 2023 Sep 4.

引用本文的文献

1
Ferroptosis and non-coding RNAs in breast cancer: insights into CAF and TAM interactions.乳腺癌中的铁死亡与非编码RNA:对癌症相关成纤维细胞和肿瘤相关巨噬细胞相互作用的见解
Discov Oncol. 2025 Aug 31;16(1):1658. doi: 10.1007/s12672-025-03507-x.
2
Constructing a ferroptosis-related prognostic model for osteosarcoma based on scRNA-seq dataset and WGCNA analysis.基于单细胞RNA测序数据集和加权基因共表达网络分析构建骨肉瘤铁死亡相关预后模型。
Int J Clin Exp Pathol. 2025 Jul 15;18(7):335-350. doi: 10.62347/QVON7675. eCollection 2025.
3
Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics.

本文引用的文献

1
Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer.活性氧物种和铁死亡在炎症和结肠癌的交汇点。
Antioxid Redox Signal. 2023 Sep;39(7-9):551-568. doi: 10.1089/ars.2023.0246. Epub 2023 Mar 29.
2
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers.ACSL3和ACSL4在铁死亡和癌症中的不同作用。
Cancers (Basel). 2022 Nov 29;14(23):5896. doi: 10.3390/cancers14235896.
3
Biomimetic photosensitizer nanocrystals trigger enhanced ferroptosis for improving cancer treatment.仿生光敏剂纳米晶体触发增强的铁死亡以改善癌症治疗。
活性氧:癌症信号通路动力学调控中的双刃剑
Cells. 2025 Aug 6;14(15):1207. doi: 10.3390/cells14151207.
4
Ciclopirox suppresses poxvirus replication by targeting iron metabolism.环吡酮通过靶向铁代谢来抑制痘病毒复制。
bioRxiv. 2025 Jul 24:2025.07.24.666650. doi: 10.1101/2025.07.24.666650.
5
The Molecular Interplay Between p53-Mediated Ferroptosis and Non-Coding RNAs in Cancer.癌症中p53介导的铁死亡与非编码RNA之间的分子相互作用
Int J Mol Sci. 2025 Jul 9;26(14):6588. doi: 10.3390/ijms26146588.
6
Ferroptosis: A critical link to treatment resistance in esophageal carcinoma.铁死亡:食管癌治疗耐药的关键环节。
iScience. 2025 Jun 14;28(7):112901. doi: 10.1016/j.isci.2025.112901. eCollection 2025 Jul 18.
7
The role of in regulating proliferation and invasion in U251 glioblastoma cells.在U251胶质母细胞瘤细胞中调节增殖和侵袭的作用。 (原文“of”后面缺少具体内容)
Contemp Oncol (Pozn). 2025;29(2):195-205. doi: 10.5114/wo.2025.150649. Epub 2025 May 12.
8
Phytochemicals as modulators of ferroptosis: a novel therapeutic avenue in cancer and neurodegeneration.植物化学物质作为铁死亡的调节剂:癌症和神经退行性疾病治疗的新途径。
Mol Biol Rep. 2025 Jun 25;52(1):636. doi: 10.1007/s11033-025-10752-4.
9
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers.绕过守护者:p53 突变型癌症中的程序性细胞死亡途径
Cell Mol Biol Lett. 2025 Jun 14;30(1):68. doi: 10.1186/s11658-025-00751-5.
10
TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK/AKT/Mtor-gpx4 cascade.TSPAN15通过FAK/AKT/Mtor-gpx4级联维持ITGB1稳定性,以阻断吉西他滨诱导的胰腺导管腺癌铁死亡。
Redox Biol. 2025 Jun 8;85:103721. doi: 10.1016/j.redox.2025.103721.
J Control Release. 2022 Dec;352:1116-1133. doi: 10.1016/j.jconrel.2022.11.026. Epub 2022 Nov 21.
4
Engineering Fe/Mn-doped zinc oxide nanosonosensitizers for ultrasound-activated and multiple ferroptosis-augmented nanodynamic tumor suppression.工程化铁/锰掺杂氧化锌纳米声敏剂用于超声激活和多重铁死亡增强的纳米动力学肿瘤抑制
Mater Today Bio. 2022 Oct 5;16:100452. doi: 10.1016/j.mtbio.2022.100452. eCollection 2022 Dec.
5
A Sonication-Activated Valence-Variable Sono-Sensitizer/Catalyst for Autography Inhibition/Ferroptosis-Induced Tumor Nanotherapy.声激活价变声敏剂/催化剂用于声动力学抑制/铁死亡诱导的肿瘤纳米治疗。
Angew Chem Int Ed Engl. 2022 Nov 25;61(48):e202212021. doi: 10.1002/anie.202212021. Epub 2022 Oct 26.
6
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.基于单细胞 RNA 测序,APOC1 抑制通过铁死亡途径促进 M2 向 M1 巨噬细胞的转化,并增强肝细胞癌的抗 PD1 免疫治疗。
Redox Biol. 2022 Oct;56:102463. doi: 10.1016/j.redox.2022.102463. Epub 2022 Sep 2.
7
An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.一种酶工程化的无孔铜(I)配位聚合物纳米平台,用于基于铜死亡的协同癌症治疗。
Adv Mater. 2022 Oct;34(43):e2204733. doi: 10.1002/adma.202204733. Epub 2022 Sep 23.
8
Self-Assembled Aza-Boron-Dipyrromethene for Ferroptosis-Boosted Sonodynamic Therapy.自组装氮杂硼二吡咯甲川染料用于促进铁死亡的声动力学治疗。
Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202210174. doi: 10.1002/anie.202210174. Epub 2022 Sep 2.
9
Engineering dual catalytic nanomedicine for autophagy-augmented and ferroptosis-involved cancer nanotherapy.用于自噬增强和铁死亡参与的癌症纳米治疗的工程化双催化纳米药物
Biomaterials. 2022 Aug;287:121668. doi: 10.1016/j.biomaterials.2022.121668. Epub 2022 Jul 5.
10
The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death.用于去势抵抗性前列腺癌的多肽 PSMA 靶向嵌合抗原受体工程化自然杀伤细胞的建立和诱导铁死亡相关细胞死亡。
Cancer Commun (Lond). 2022 Aug;42(8):768-783. doi: 10.1002/cac2.12321. Epub 2022 Jun 15.